Caris Life Sciences, Inc. (CAI) Financials
Annual revenue, profitability and per-share results for Caris Life Sciences, Inc., as reported in SEC filings.
Revenue • FY2025
$812.03M
Net income • FY2025
-$68.09M
Diluted EPS • FY2025
-$3.22
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $812.03M | -$68.09M | — | -$3.22 | $66.89M | 5.6% | — |
Figures as reported in Caris Life Sciences, Inc.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a CAI filing.
Get an email when CAI files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.